Atrophic vaginitis is typically associated with the hypoestrogenic state of menopause. However, lactation also decreases estrogen levels and can cause symptomatic urogenital atrophy. Discussion of ...

Context Explanation

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ... The genitourinary syndrome of menopause (vaginal atrophy or atrophic vaginitis) frequently affects women transitioning to menopause.

Insight Material

It’s a condition where the lining of your vagina gets drier and thinner from a lack of estrogen. Vaginal atrophy used to be a medical term for thinning and drying of the vagina's inner lining, often after menopause. Another name for it was atrophic vaginitis. Atrophic vulvovaginitis means thinned genital tissues in women; the vaginal tissue is most often symptomatic. Treatment involves measures such as moisturiser use, cleansers, and oestrogen treatment.

Final Conclusion

Vaginal atrophy (atrophic vaginitis) causes thinned tissue and dryness during menopause due to low estrogen. Treatments like lubricants and hormone therapy can help relieve symptoms. Symptoms like vaginal dryness and painful orgasms are common in postmenopausal atrophic vaginitis. If you’re experiencing them, an OB-GYN or doctor can prescribe treatments to help. Vaginal atrophy is a change of the vagina that develops when there is a significant decrease in levels of the female hormone estrogen. The condition also is called atrophic vaginitis.

Estrogen, which is produced by the ovaries, plays a vital role in keeping vaginal tissues lubricated and healthy. Vaginal atrophy (atrophic vaginitis) is thinning, drying and inflammation of the vaginal walls that may occur when your body has less oestrogen. Vaginal atrophy occurs most often around or after the menopause. When a woman’s estrogen levels decrease, these tissues can become thin, inflexible, and dry.